Transcription of Genetic Testing for Hereditary Cancer Susceptibility Syndromes
{{id}} {{{paragraph}}}
Page 1 of 33 Medical Coverage Policy: 0518 Medical Coverage Policy Effective Date .. 7/15/2021 Next Review Date .. 7/15/2022 Coverage Policy Number .. 0518 Genetic Testing for Hereditary Cancer Susceptibility Syndromes Table of Contents Overview .. 2 Coverage Policy .. 2 General Criteria for Germline Pathogenic or Likely Pathogenic Variant Genetic Testing : Hereditary Cancer Susceptibility /Risk Assessment .. 2 Germline Testing Following Identification of a Somatic Pathogenic or Likely Pathogenic Variant .. 3 Germline Pathogenic or Likely Pathogenic Variant Genetic Testing for Hereditary Cancer Susceptibility Syndromes .. 3 General Background .. 5 Genetic Counseling .. 6 General Criteria for Germline Pathogenic or Likely Pathogenic Variant Testing for Hereditary Cancer Susceptibility /Risk Assessment.
surgical decision making in an individual recently diagnosed with early stage breast cancer who: o has evaluated the individual o completed a three-generation pedigree o intends to engage in post-test follow-up counseling or, if a breast surgeon treating a patient with recently diagnosed breast cancer, intends to refer to an appropriately
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}